StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

GRI Bio ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for GRI Bio

GRI Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More GRI Bio figures

See a number that looks wrong?